ITERUM THERAPEUTICS

iterum-therapeutics-logo

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives. It aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterumโ€™s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive, and anaerobic bacteria resistant to other antibiotics.

#SimilarOrganizations #People #Financial #Event #Website #More

ITERUM THERAPEUTICS

Social Links:

Industry:
Medical Pharmaceutical Therapeutics

Founded:
2015-01-01

Address:
Dublin, Dublin, Ireland

Country:
Ireland

Website Url:
http://www.iterumtx.com

Total Employee:
11+

Status:
Active

Contact:
+353 1 903 8920

Total Funding:
193.4 M USD

Technology used in webpage:
ReCAPTCHA COVID-19 ReCAPTCHA V2 Amazon S3 Ireland Domain Redirect ON24


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

lenz-therapeutics-logo

LENZ Therapeutics

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.


Current Advisors List

brent-ahrens_image

Brent Ahrens Board Member @ Iterum Therapeutics
Board_member

mark-chin_image

Mark Chin Board Of Director @ Iterum Therapeutics
Board_member

ron-hunt_image

Ron Hunt Board Member @ Iterum Therapeutics
Board_member

corey-n-fishman_image

Corey N. Fishman Board Member @ Iterum Therapeutics
Board_member

shahzad-malik_image

Shahzad Malik Board Member @ Iterum Therapeutics
Board_member

patrick-heron_image

Patrick Heron Board Member @ Iterum Therapeutics
Board_member

michael-dunne_image

Michael Dunne Board Member @ Iterum Therapeutics
Board_member

david-g-kelly_image

David G. Kelly Board Member @ Iterum Therapeutics
Board_member

Current Employees Featured

john-j-white_image

John J. White
John J. White Co Founder @ Iterum Therapeutics
Co Founder

corey-n-fishman_image

Corey N. Fishman
Corey N. Fishman CEO @ Iterum Therapeutics
CEO
2015-11-01

louise-barrett_image

Louise Barrett
Louise Barrett SVP of Legal Affairs @ Iterum Therapeutics
SVP of Legal Affairs

judith-m-matthews_image

Judith M. Matthews
Judith M. Matthews CFO @ Iterum Therapeutics
CFO

steven-i-aronin_image

Steven I. Aronin
Steven I. Aronin Head of Clinical Development and Senior Vice President @ Iterum Therapeutics
Head of Clinical Development and Senior Vice President

tom-loughman_image

Tom Loughman
Tom Loughman Vice President and CMC Head @ Iterum Therapeutics
Vice President and CMC Head

not_available_image

Sailaja Puttagunta
Sailaja Puttagunta Chief Medical Officer @ Iterum Therapeutics
Chief Medical Officer
2021-12-01

Founder


corey-n-fishman_image

Corey N. Fishman

john-j-white_image

John J. White

Stock Details


Company's stock symbol is NASDAQ:ITRM

Investors List

sarissa-capital-management_image

Sarissa Capital Management

Sarissa Capital Management investment in Post-IPO Equity - Iterum Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Iterum Therapeutics

carb-x_image

CARB-X

CARB-X investment in Grant - Iterum Therapeutics

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series B - Iterum Therapeutics

advent-life_image

Advent Life Sciences

Advent Life Sciences investment in Series B - Iterum Therapeutics

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Series B - Iterum Therapeutics

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series B - Iterum Therapeutics

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series B - Iterum Therapeutics

arix-bioscience_image

Arix Bioscience

Arix Bioscience investment in Series B - Iterum Therapeutics

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series B - Iterum Therapeutics

Key Employee Changes

Date New article
2021-12-13 Iterum Therapeutics Appoints Sailaja Puttagunta, MD as Chief Medical Officer

Official Site Inspections

http://www.iterumtx.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.56 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Iterum Therapeutics" on Search Engine